LGND
Ligand Pharmaceuticals Inc.
$237.25
0.69%
+1.63
Notify me if price changes either direction
Buy LGND stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
4.7B
Enterprise value
4.4B
Trailing PE
30.859375
Forward PE
20.942556
PEG Ratio
-0.44285206980519
Enterprise to EBITDA
32.893
Enterprise to revenue
16.112
Price to book MRQ
4.7596097
Price to sales TTM
17.304724
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
274.5M
EBITDA
94.5M
Diluted EPS TTM
7.68
Total Cash (MRQ)
779.4M
Current ratio (MRQ)
21.281
Operating Cash Flow (TTM)
123.5M
LGND trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
